@article {Visweswaran2021.03.15.21253596, author = {Shyam Visweswaran and Malarkodi J. Samayamuthu and Michele Morris and Griffin M. Weber and Douglas MacFadden and Philip Trevvett and Jeffrey G. Klann and Vivian Gainer and Barbara Benoit and Shawn N. Murphy and Lav Patel and Nebojsa Mirkovic and Yuliya Borovskiy and Robert D. Johnson and Matthew C. Wyatt and Amy Y. Wang and Robert W. Follett and Ngan Chau and Wenhong Zhu and Mark Abajian and Amy Chuang and Neil Bahroos and Phillip Reeder and Donglu Xie and Jennifer Cai and Elaina R. Sendro and Robert D. Toto and Gary S. Firestein and Lee M. Nadler and Steven E. Reis}, title = {Development of a COVID-19 Application Ontology for the ACT Network}, elocation-id = {2021.03.15.21253596}, year = {2021}, doi = {10.1101/2021.03.15.21253596}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {Clinical data networks that leverage large volumes of data in electronic health records (EHRs) are significant resources for research on coronavirus disease 2019 (COVID-19). Data harmonization is a key challenge in seamless use of multisite EHRs for COVID-19 research. We developed a COVID-19 application ontology in the national Accrual to Clinical Trials (ACT) network that enables harmonization of data elements that that are critical to COVID-19 research. The ontology contains over 50,000 concepts in the domains of diagnosis, procedures, medications, and laboratory tests. In particular, it has computational phenotypes to characterize the course of illness and outcomes, derived terms, and harmonized value sets for SARS-CoV-2 laboratory tests. The ontology was deployed and validated on the ACT COVID-19 network that consists of nine academic health centers with data on 14.5M patients. This ontology, which is freely available to the entire research community on GitHub at https://github.com/shyamvis/ACT-COVID-Ontology, will be useful for harmonizing EHRs for COVID-19 research beyond the ACT network.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under grant numbers UL1 TR000005-09S1 and UL1 TR001857-01S1, and by the National Library of Medicine of the National Institutes of Health under award numbers R01 LM012095. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The research was approved by the University of Pittsburgh{\textquoteright}s IRB under protocol number STUDY19080059.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe ontology files are freely available at GitHub. https://github.com/shyamvis/ACT-COVID-Ontology}, URL = {https://www.medrxiv.org/content/early/2021/04/14/2021.03.15.21253596}, eprint = {https://www.medrxiv.org/content/early/2021/04/14/2021.03.15.21253596.full.pdf}, journal = {medRxiv} }